SLC39A8 and Cognitive impairment: In PheWAS, we also find that SLC39A8 is associated with the cognition test scores (i.e., fluid intelligence and prospective memory), which aligns with the known characteristics of AD as a progressive neurodegenerative disorder characterized by memory loss and cognitive deficits.